4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000032
Senior Vice President, Finance sold 395 shares at $41.30 ($16,314)
From the SEC's structured data for this filing
Trades in this filing
Agarwal Arjun · Senior Vice President, Finance
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-16 | Sale : show line 1 in the form | −395 | $41.30 | $16,314 | 18,863 | D |
| Open-market sales · 395 sh · avg $41.30 · $16,314 | ||||||
Loading xslF345X05/form4.xml…